Our Company

OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases.

Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics has 70 employees and is listed on Euronext Paris.

Corporate presentation

Immuno-Oncology and Auto-Immune Diseases: We are armed to fight

Download our Corporate Presentation

Management team

The Company relies upon its international and complementary team of experts involved in the research and optimisation of drug candidates, pharmaceutical development and drug registration to develop the next wave of novel immunotherapies.

Board of Directors

Members of the Board of Directors combine international expertise in both drug development, marketing, industry and finance, with experience in listed biotech companies.



					

To receive OSE Immunotherapeutics’ latest news